Vimarsana
Biggest News Aggregation in the World

Page 26 - Multiple System Atrophy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple System Atrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple System Atrophy Today - Breaking & Trending Today

Parkinsonian Symptoms — Capturing a Comprehensive Picture with Fit-for-Purpose Assessments, Upcoming Webinar Hosted by Xtalks - Vimarsana News

Parkinsonian Symptoms — Capturing a Comprehensive Picture with Fit-for-Purpose Assessments, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) April 05, 2023 -- This webinar will discuss key considerations for instrument selection, data quality assurance and innovative enabling

Source: prweb.com
Alterity Therapeutics : Enrols First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy - Form 6-K - Vimarsana News

Alterity Therapeutics : Enrols First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy - Form 6-K

Alterity Therapeutics Enrols First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA - 4... | April 4, 2023

Alterity Therapeutics Enrolls First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy - Vimarsana News

Alterity Therapeutics Enrolls First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

MELBOURNE, Australia and SAN FRANCISCO, April 04, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today... | April 4, 2023

Inhibikase Therapeutics Reports Full Year 2022 Financial Results and Highlights Recent Period Activity - Vimarsana News

Inhibikase Therapeutics Reports Full Year 2022 Financial Results and Highlights Recent Period Activity

BOSTON and ATLANTA, March 31, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of... | March 31, 2023

Some $15,000 awarded in 'Papa' Brown MSA scholarships: Here are the winners - Vimarsana News

Some $15,000 awarded in 'Papa' Brown MSA scholarships: Here are the winners

The Brown family has announced the 2023 recipients of the Coach Mike "Papa" Brown MSA Scholarship. ...